Study of Telaprevir in Subjects With Hepatic Impairment
NCT00509210
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Hepatic Insufficiency
Interventions
DRUG:
telaprevir (VX-950)
Sponsor
Vertex Pharmaceuticals Incorporated